Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS)Hideki Hirabayashi, Takehisa Hata, Toshiya Takahashi et al.|Journal of Controlled Release|2001Cited by 75
Osteotropic Drug Delivery System (ODDS) Based on Bisphosphonic Prodrug. IV Effects of Osteotropic Estradiol on Bone Mineral Density and Uterine Weight in Ovariectomized RatsJiro Fujisaki, Takehisa Hata, Yuji Tokunaga et al.|Journal of drug targeting|1998Cited by 34
Osteotropic Drug Delivery System (ODDS) Based on Bisphosphonic Prodrug. I: Synthesis and in Vivo Characterization of Osteotropic CarboxyfluoresceinJiro Fujisaki, Takehisa Hata, Takeo Hirose et al.|Journal of drug targeting|1995Cited by 30
Osteotropic Drug Delivery System (ODDS) Based on Bisphosphonic Prodrug. V. Biological Disposition and Targeting Characteristics of Osteotropic Estradiol.Jiro Fujisaki, Takehisa Hata, Toshiya Takahashi et al.|Biological and Pharmaceutical Bulletin|1997Cited by 30
Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. III: pharmacokinetics and targeting characteristics of osteotropic carboxyfluoresceinJiro Fujisaki, Takehisa Hata, Yuji Tokunaga et al.|Journal of drug targeting|1996Cited by 17